Loading...
Entry LevelFull-time
Salary Range
$16,575 - $22,425 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
AbbVie is seeking a hands-on and experienced Financial Analyst - Oncology to join our team. This role requires expertise in scenario modeling, business case creation, and knowledge of pharmaceutical business.
Key Responsibilities
- →Collaborate effectively with multiple stakeholders ensuring precise financial reporting and forecasting while fostering a cohesive work environment.
- →Develop and deploy robust financial models and analytical tools to support strategic business decision-making allowing for scenario planning.
- →Actively participate in the budgeting process and financial planning of price elements.
- →Managing monthly SG&A expenses including Advertising & Promotion and other BU related expenses
- →Deliver strategic financial insights and input to the market access head office and field team.
- →Oversee the review and approval of contracts, ensuring compliance with corporate policies and objectives.
- →Address and fulfill ad-hoc financial requests as needed to support business objectives.
- →Review and approve invoices ensuring compliance and alignment to company policies
Requirements
- ✓Expertise in scenario modeling and business case creation
- ✓Knowledge of pharmaceutical business
- ✓Experience in financial modeling and analysis
- ✓Strong understanding of budgeting and financial planning processes
- ✓Ability to manage SG&A expenses and related financial tasks
- ✓Experience with contract review and compliance
- ✓Proficiency in invoice approval and financial reporting
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
